US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

261.30

-4.7000-1.77%

Post-market: 261.760.4600+0.18%16:59 EDT

Volume:226.80K

Turnover:60.82M

Market Cap:489.80M

PE:- -

High:278.96

Open:273.29

Low:261.30

Close:266.00

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.94

T/O Rate:12.10%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Wall Street Analysts Are Bullish on Top Healthcare Picks

Nanjing King-Friend Biochemical Pharmaceutical Gets US FDA Nod for Drug Manufacturing Site; Shares Down 5%

MT Newswires Live

Ship Healthcare Advances Share Buyback Program on Tokyo Exchange

Hygeia Healthcare Holdings Co., Ltd. (6078) Gets a Buy from Huatai Securities

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT) and EyePoint Pharmaceuticals (EYPT)

Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued?

Simply Wall St.

Fisher & Paykel Healthcare Options Lapse as Vesting Conditions Go Unmet

FDA-Supported Streamlined Phase 3 Program and Strong Long-Term Asthma Upside Underpin Buy Rating with Unchanged $19 Price Target

Telix Wraps Phase 3 BiPASS Enrollment, Secures FDA NDA Pathway for Expanded PSMA-PET Use

Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference

Intelligent Bio Solutions Advances Fingerprint Drug Test Toward FDA

American Healthcare REIT Expands Portfolio With Senior Housing Acquisition

Health Care up on Defensive Bias - Health Care Roundup

Health Care Roundup: Market Talk

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Braveheart Bio to Participate in Cantor Global Healthcare Conference

BBOT to Participate in Upcoming Investor Healthcare Conferences

Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

Global Power Solutions Revives Talks on Peru Hospital Project

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/LABU/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":261.3,"timestamp":1789156800000,"preClose":266,"halted":0,"volume":226801,"hourTrading":{"tag":"盘后","latestPrice":261.76,"preClose":261.3,"latestTime":"16:59 EDT","volume":100,"amount":26210.553,"timestamp":1789160359119,"change":0.46,"changeRate":0.00176,"amplitude":0.008226},"delay":0,"changeRate":-0.017669172932330786,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Post-Mkt","change":-4.7,"latestTime":"09-11 17:08:14 EDT","open":273.29,"high":278.9613,"low":261.3,"amount":60816381.96864999,"amplitude":0.066396,"askPrice":263.59,"askSize":100,"bidPrice":261.12,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":278.651,"aum":522328218.83,"dividendRate":0.003844,"bidAskSpread":0.002964,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":261.76,"preClose":261.3,"latestTime":"16:59 EDT","volume":100,"amount":26210.553,"timestamp":1789160359119,"change":0.46,"changeRate":0.00176,"amplitude":0.008226},"volumeRatio":0.937399,"impliedVol":0.8728,"impliedVolPercentile":0.3227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.937399,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.066396,"preClose":266,"low":261.3,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":261.3,"committee":-0.980198,"eps":0,"divideRate":0.003844,"volume":226801,"delay":0,"ttmEps":0,"open":273.29,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664589238","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589238?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:40","pubTimestamp":1788334818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Cabaletta Bio (CAB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU0757428866.USD","IBBQ","LU2456880835.USD","LU1585245621.USD","IE00B2B36J28.USD","VRTX","LU0566484027.USD","LU2362540622.SGD","IE00B19Z3581.USD","LU0061475181.USD","LU0234570918.USD","IE00B4R5TH58.HKD","LU1674673428.USD","IE00BZ9MQY76.HKD","BK4533","BBH","IE00B19Z3B42.SGD","SG9999013999.USD","LU2468319806.SGD","BK4137","LU0079474960.USD","IE00B19Z9P08.USD","GNMX","XLV","LU0823416689.USD","LU0320765992.SGD","LU1035775433.USD","IBB","SG9999001176.USD","LU0889565916.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU0029874061.USD","LU0109394709.USD","BK4581","PBE","TBXU","VERX","HCSG","LU0432979614.USD","BIB","LU1674673691.USD","LU2324357040.USD","IDNA","LABU","BK4567","LU2417539215.USD","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891417","title":"Nanjing King-Friend Biochemical Pharmaceutical Gets US FDA Nod for Drug Manufacturing Site; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891417","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891417?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:14","pubTimestamp":1788333289,"startTime":"0","endTime":"0","summary":"Nanjing King-Friend Biochemical Pharmaceutical  subsidiary Emerge Bioscience obtained U.S. Food and Drug Administration approval to manufacture adalimumab injection at Kingfriend's manufacturing facility.The biosimilar, sold under the brand YUSIMRY, was originally approved for nine indications including rheumatoid arthritis, Crohn's disease and psoriasis, according to a Wednesday filing with the Shanghai bourse.Shares of the pharmaceutical company declined 5% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK0186","603707","BK4588","LABU","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664289136","title":"Ship Healthcare Advances Share Buyback Program on Tokyo Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2664289136","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664289136?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:53","pubTimestamp":1788332018,"startTime":"0","endTime":"0","summary":"Ship Healthcare Holdings ( ($JP:3360) ) has shared an announcement. Ship Healthcare Holdings has disclosed the acquisition of 525,400 of its own co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ship-healthcare-advances-share-buyback-program-on-tokyo-exchange?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ship-healthcare-advances-share-buyback-program-on-tokyo-exchange?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","BK4581","XBI","LABU","BK4137","HCSG","BK4585","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664896374","title":"Hygeia Healthcare Holdings Co., Ltd. (6078) Gets a Buy from Huatai Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2664896374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664896374?lang=en_us&edition=fundamental","pubTime":"2026-09-02 13:06","pubTimestamp":1788325600,"startTime":"0","endTime":"0","summary":"Huatai Securities analyst maintained a Buy rating on Hygeia Healthcare Holdings Co., Ltd. yesterday and set a price target of HK$18.78. Currently, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/hygeia-healthcare-holdings-co-ltd-6078-gets-a-buy-from-huatai-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/hygeia-healthcare-holdings-co-ltd-6078-gets-a-buy-from-huatai-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4585","XBI","XLV","HCSG","BK4581","BK4137","LU0029874061.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664389543","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT) and EyePoint Pharmaceuticals (EYPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664389543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664389543?lang=en_us&edition=fundamental","pubTime":"2026-09-02 12:30","pubTimestamp":1788323420,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Arcturus Therapeutics (ARCT) and EyePoint Pharmaceuticals (EYPT)....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-arcturus-therapeutics-arct-and-eyepoint-pharmaceuticals-eypt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-arcturus-therapeutics-arct-and-eyepoint-pharmaceuticals-eypt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","LU0320765992.SGD","LU0029874061.USD","BK4139","LU0889565916.HKD","BK4585","LU2324357040.USD","BK4007","BK4137","LU0109394709.USD","LABU","XLV","LU0128526141.USD","ARCT","XBI","EYPT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664389542","title":"Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664389542","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664389542?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:22","pubTimestamp":1788319331,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries (NYSE:TEVA) is in focus after the U.S. FDA accepted its New Drug Application for ecopipam, a potential first-in-class treatment for pediatric Tourette syndrome with Orphan Drug and Priority Review status.\nAt a share price of US$36.19, Teva Pharmaceutical Industries has a 1-year total shareholder return of 93.01% and a 5-year total shareholder return of 282.96%. This suggests strong long-term momentum, even after a recent 5.01% decline in the 7-day share price...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/is-teva-pharmaceutical-industries-teva-undervalued-on-its-fd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/is-teva-pharmaceutical-industries-teva-undervalued-on-its-fd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4557","LU2324357040.USD","TEVA","BK4584","BK4566","LABU","BK4559","BK4588","BK4007","BK4585","BK4596","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664893516","title":"Fisher & Paykel Healthcare Options Lapse as Vesting Conditions Go Unmet","url":"https://stock-news.laohu8.com/highlight/detail?id=2664893516","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664893516?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:17","pubTimestamp":1788319033,"startTime":"0","endTime":"0","summary":"An announcement from Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) is now available. Fisher & Paykel Healthcare Corporation Limited ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-options-lapse-as-vesting-conditions-go-unmet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-options-lapse-as-vesting-conditions-go-unmet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4588","BK8004","LABU","XLV","BK4585","BK4581","FPH.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386716","title":"FDA-Supported Streamlined Phase 3 Program and Strong Long-Term Asthma Upside Underpin Buy Rating with Unchanged $19 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386716?lang=en_us&edition=fundamental","pubTime":"2026-09-02 08:45","pubTimestamp":1788309918,"startTime":"0","endTime":"0","summary":"Kate Dellorusso, an analyst from LifeSci Capital, maintained the Buy rating on Upstream Bio, Inc.. The associated price target remains the same wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/fda-supported-streamlined-phase-3-program-and-strong-long-term-asthma-upside-underpin-buy-rating-with-unchanged-19-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/fda-supported-streamlined-phase-3-program-and-strong-long-term-asthma-upside-underpin-buy-rating-with-unchanged-19-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664649208","title":"Telix Wraps Phase 3 BiPASS Enrollment, Secures FDA NDA Pathway for Expanded PSMA-PET Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2664649208","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664649208?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:40","pubTimestamp":1788302458,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an announcement. Telix Pharmaceuticals has completed enrollment of 350 patients in its Phase 3 Bi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wraps-phase-3-bipass-enrollment-secures-fda-nda-pathway-for-expanded-psma-pet-use?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wraps-phase-3-bipass-enrollment-secures-fda-nda-pathway-for-expanded-psma-pet-use?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4588","LABU","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861774","title":"Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861774","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861774?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:07","pubTimestamp":1788300420,"startTime":"0","endTime":"0","summary":"EAGLE, Idaho, Sept.  01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354734/0/en/pennant-group-to-participate-in-the-2026-jefferies-healthcare-services-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","BK4581","LU0128526141.USD","BK4137","HCSG","BK4196","XLV","LABU","PNTG","BK4585","XBI","BK4588","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664648238","title":"Intelligent Bio Solutions Advances Fingerprint Drug Test Toward FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2664648238","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664648238?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:41","pubTimestamp":1788298898,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions ( ($INBS) ) has issued an announcement. On September 1, 2026, Intelligent Bio Solutions Inc. reported results from a mult...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intelligent-bio-solutions-advances-fingerprint-drug-test-toward-fda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intelligent-bio-solutions-advances-fingerprint-drug-test-toward-fda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861174","title":"American Healthcare REIT Expands Portfolio With Senior Housing Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861174","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861174?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:27","pubTimestamp":1788298055,"startTime":"0","endTime":"0","summary":"American Healthcare REIT, Inc. ( ($AHR) ) has shared an update. On September 1, 2026, American Healthcare REIT, Inc. announced it had acquired six ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-expands-portfolio-with-senior-housing-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/american-healthcare-reit-expands-portfolio-with-senior-housing-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AHR","IQRA","IVRA","LABU","REIT","BK4585","PSCF","BK4225","RJMG","BK4588","BK4581","BPRE","DFRA","MDIV","RNTY","XBI","YLDW","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861948","title":"Health Care up on Defensive Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861948","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861948?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:16","pubTimestamp":1788297360,"startTime":"0","endTime":"0","summary":"Health-care companies rose as traders rotated into defensive sectors in light of a spike in oil futures and Treasury yields.Medtronic raised its growth projections for the year after the maker of medical devices such as pacemakers and defibrillators posted growth in fiscal first-quarter profit and sales.Novartis shares rose after the Swiss drugmaker reported positive results from two late-stage trials in the most common form of multiple sclerosis, saying its new pill helped patients experience fewer flare-ups.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XLV","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861887","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861887?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:50","pubTimestamp":1788295800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1035 ET - Investors were cautious on Novartis's clinical trials ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4585","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869243","title":"aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869243","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869243?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:36","pubTimestamp":1788294960,"startTime":"0","endTime":"0","summary":"Company anticipates response from FDA by mid-September 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease.SAN DIEG","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354637/0/en/atyr-pharma-provides-update-on-timing-of-regulatory-response-for-planned-phase-3-study-of-efzofitimod-in-pulmonary-sarcoidosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664086926","title":"Braveheart Bio to Participate in Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664086926","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664086926?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:30","pubTimestamp":1788294600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354630/0/en/braveheart-bio-to-participate-in-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU0472753341.HKD","LU0203347892.USD","BK4531","BK4007","BK4585","XBI","BK4567","LU0069063385.USD","BK4588","LU0128526141.USD","LU0124676726.USD","BK4581","LU0057025933.USD","BK4533","LU0289961442.SGD","BK4149","LU0689626769.HKD","MADE","LU0029874061.USD","LU0154245673.USD","LU0154245756.USD","LU0289739343.SGD","IE000M9KFDE8.USD","LABU","CMI","BK4137","LU2463526074.USD","BRVE","HCM","HCSG","LU0511384066.AUD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886917","title":"BBOT to Participate in Upcoming Investor Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886917","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886917?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293100,"startTime":"0","endTime":"0","summary":"Investor Contact:. Investors@BBOTx.com. Media Contact:. Inizio Evoke Comms. Jake.robison@inizioevoke.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354587/0/en/bbot-to-participate-in-upcoming-investor-healthcare-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XBI","LU0029874061.USD","BK4139","XLV","HCSG","LU0128526141.USD","LABU","BK4581","BK4588","BK4137","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869470","title":"Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869470","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869470?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293100,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it will participate in a fireside chatat the Morga","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354590/0/en/veracyte-to-participate-in-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VCYT","BK4581","BK4588","XBI","LABU","BK4139","LU0029874061.USD","MS","HCSG","BK4137","FBT","XLV","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869298","title":"Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869298","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869298?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293100,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing inn","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354577/0/en/sight-sciences-to-present-at-the-upcoming-morgan-stanley-global-healthcare-conference-on-september-15.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4137","BK4585","BK4588","HCSG","LU0128526141.USD","BK4082","BK4539","SGHT","XBI","LABU","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866891","title":"Global Power Solutions Revives Talks on Peru Hospital Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866891","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866891?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:04","pubTimestamp":1788289473,"startTime":"0","endTime":"0","summary":"Minaean SP Construction ( ($TSE:PWER) ) has provided an update. Global Power Solutions Corp. says Peru’s social health insurance authority EsSalud ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/global-power-solutions-revives-talks-on-peru-hospital-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/global-power-solutions-revives-talks-on-peru-hospital-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UN","IYH","UNHU","BK4588","BK4585","PWER","XBI","UNHG","UNHW","XLV","BK4581","LABU","IHF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":16,"totalSize":415,"code":"91000000","status":"200"}]}}